8-K Announcements
6Material company update
Dec 4, 2025·SEC
Material company update
Dec 1, 2025·SEC
Material company update
Oct 16, 2025·SEC
Translational Development Acquisition Corp.(TDACW)Earnings, Financials & Key Ratios
TDACW•NASDAQ
$1.45
3.9× P/E·Price updated Jul 7, 2026
AboutTranslational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.Show more
- EBITDA-$945K-1230.2%
- Net Income$6M+9059.7%
- EPS (Diluted)0.37+2384.0%
- ROE3.7%+4484.5%
TDACW Price & Volume
Translational Development Acquisition Corp. (TDACW) stock price & volume — 10-year historical chart
Loading chart...
Persistent Liquidity Constraints Threaten Shell Entity Viability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent Liquidation and Insolvency
Key Thesis Takeaways
- Translational Development Acquisition Corp.
- remains a pre-revenue shell entity characterized by a complete lack of operational activity and a deteriorating financial position.
- The company's reliance on non-operating accounting adjustments to report net income masks a fundamental inability to generate sustainable cash flow or maintain adequate liquidity.
- Investors should exercise extreme caution as the entity's nominal cash reserves and high insolvency risk suggest a limited runway for securing a viable business combination.
Verdict Logic
the company's severe liquidity constraints, evidenced by a current ratio of 0.09 and persistent cash burn, suggest an imminent risk of insolvency or delisting.
TDACW Growth Metrics
Translational Development Acquisition Corp. (TDACW) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years20.22%
3 Years-
TTM339.67%
EPS CAGR
10 Years-
5 Years0.55%
3 Years-
TTM-18.54%
Return on Capital
10 Years-136.69%
5 Years-238.42%
3 Years-316.64%
Last Year-0.53%
Peers Comparison
Key metrics vs top competitors for Translational Development Acquisition Corp. (TDACW)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.45 | $25.01M | 3.92 | -100% | — | 3.7% | — | |
| $0.37 | $3.35M | -0.24 | -10.3% | -3089.55% | -423.84% | — | |
| $8.55 | $9.62M | -0.23 | -83.94% | — | — | — | |
| $208.23 | $35.34B | 26.56 | 5.87% | 8.33% | 22.11% | — | |
| $228.68 | $11.01B | -78.58 | -0.85% | -4.59% | -5.66% | — | |
| $168.72 | $12.92B | 58.18 | -0.37% | 5.35% | 4.7% | — |
Compare TDACW vs Peers
Translational Development Acquisition Corp. (TDACW) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
TDACW SEC Filings & Documents
Translational Development Acquisition Corp. (TDACW) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when TDACW posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
TDACW Frequently Asked Questions
Translational Development Acquisition Corp. (TDACW) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
How fast is Translational Development Acquisition Corp. growing?
Translational Development Acquisition Corp. (TDACW) saw revenue decline by 100.0% over the past year.
Is TDACW profitable?
Yes, Translational Development Acquisition Corp. (TDACW) is profitable, generating $6.2M in net income for fiscal year 2025.
Dividend & Returns
What is TDACW's return on equity?
Translational Development Acquisition Corp. (TDACW) has a return on equity (ROE) of 3.7%. This is below average, suggesting room for improvement.
What is Translational Development Acquisition Corp.'s free cash flow?
Translational Development Acquisition Corp. (TDACW) had negative free cash flow of $0.7M in fiscal year 2025, likely due to heavy capital investments.